Unpacking the Latest Options Trading Trends in Viking Therapeutics
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale trades within a strike price range from $15.0 to $105.0 in the last 30 days. Financial giants have made a conspicuous bearish move on Viking Therapeutics. Our analysis of options history for Viking Therapeutics (NASDAQ:VKTX) revealed 34 unusual trades.
金融巨头对Viking Therapeutics采取了明显的看淡举措。我们对Viking Therapeutics（纳斯达克: VKTX）的期权历史进行分析后发现了34笔飞凡交易。
Delving into the details, we found 38% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $146,300, and 29 were calls, valued at $2,404,204.
深入了解细节后，我们发现38%的交易者看好，而47%显示了看淡倾向。在我们发现的所有交易中，有5笔看跌期权，价值146,300美元，而有29笔看涨期权，价值2,404,204美元。
What's The Price Target?
目标价是多少？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $105.0 for Viking Therapeutics over the last 3 months.
考虑到这些合约的成交量和未平仓合约量，看来大鳄们在过去3个月一直把矛头指向Viking Therapeutics的目标价区间15.0至105.0美元。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale trades within a strike price range from $15.0 to $105.0 in the last 30 days.
在交易期权时，查看成交量和未平仓合约量是一个强有力的举措。这些数据有助于您跟踪Viking Therapeutics特定行权价格的期权的流动性和利益。下面，我们可以观察Viking Therapeutics所有鲸鱼交易在过去30天内在15.0至105.0美元行权价区间内的看涨和看跌期权的成交量和未平仓合约量的演变。
Viking Therapeutics 30-Day Option Volume & Interest Snapshot
Viking Therapeutics 30天期权成交量与未平仓合约快照
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BULLISH | 12/20/24 | $9.0 | $8.6 | $8.9 | $75.00 | $213.6K | 745 | 252 |
| VKTX | CALL | SWEEP | BULLISH | 01/16/26 | $62.9 | $59.0 | $61.34 | $15.00 | $191.7K | 154 | 31 |
| VKTX | CALL | TRADE | NEUTRAL | 12/20/24 | $8.1 | $7.5 | $7.8 | $77.50 | $187.2K | 14 | 493 |
| VKTX | CALL | SWEEP | BULLISH | 01/17/25 | $25.5 | $25.3 | $25.5 | $50.00 | $127.5K | 863 | 360 |
| VKTX | CALL | TRADE | BEARISH | 01/17/25 | $25.5 | $25.4 | $25.4 | $50.00 | $127.0K | 863 | 310 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看涨 | 交易 | 看好 | 12/20/24 | 9.0美元 | $8.6美元 | $8.9 | $75.00 | 213.6千美元 | 745 | 252 |
| VKTX | 看涨 | SWEEP | 看好 | 01/16/26 | $62.9 | $59.0 | $61.34 | 15.00美元 | $191.7K | 154 | 31 |
| VKTX | 看涨 | 交易 | 中立 | 12/20/24 | $8.1 | $7.5 | $7.8 | $77.50 | 187.2千美元 | 14 | 493 |
| VKTX | 看涨 | SWEEP | 看好 | 01/17/25 | 25.5美元 | $25.3 | 25.5美元 | $50.00 | $127.5K | 863 | 360 |
| VKTX | 看涨 | 交易 | 看淡 | 01/17/25 | 25.5美元 | 25.4美元 | 25.4美元 | $50.00 | $127.0K | 863 | 310 |
About Viking Therapeutics
关于Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家卫生服务提供商，专门从事代谢和内分泌障碍领域的生物制药开发。该公司的临床项目流水线包括VK2809、VK5211、VK0214产品。VK2809和VK0214是口服、组织和受体亚型选择性的甲状腺激素受体β激动剂。VK5211是一种口服、非类固醇选择性雄激素受体调节剂。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析与Viking Therapeutics相关的期权交易活动后，我们转而更近距离地关注该公司的业绩表现。
Present Market Standing of Viking Therapeutics
维京疗法现行市状况
- Currently trading with a volume of 2,977,355, the VKTX's price is down by -1.41%, now at $73.47.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 99 days.
- 目前成交量为2,977,355，VKTX的价格下跌了-1.41％，现在为$73.47。
- RSI读数表明该股目前可能接近超买水平。
- 预计财报将在99天后发布。
Professional Analyst Ratings for Viking Therapeutics
Viking Therapeutics的专业分析师评级
In the last month, 2 experts released ratings on this stock with an average target price of $90.0.
上个月，有2位专家发布了对该股票的评级，平均目标价为90.0美元。
Turn $1000 into $1270 in just 20 days?
在短短20天内，将1000美元变成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* An analyst from HC Wainwright & Co. downgraded its action to Buy with a price target of $90. * Reflecting concerns, an analyst from HC Wainwright & Co. lowers its rating to Buy with a new price target of $90.
20年期期权交易员揭示了他的单线图技术，显示何时买入和卖出。复制他的交易，平均每20天获利27％。点击此处进行访问。* HC Wainwright的一位分析师将其评级下调为买入，并设定了90美元的目标价。* 反映担忧，HC Wainwright的一位分析师将其评级降至买入，设定了新的90美元目标价。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供更高利润的潜力。精明的交易者通过持续的教育、战略性交易调整、利用各种因子以及保持对市场动态的敏锐感来减轻这些风险。使用Benzinga Pro随时提醒进行实时交易，跟踪viking therapeutics的最新期权交易。
